Abstract
Hashimotos thyroiditis, the most common form of autoimmune thyroid disease, is characterised by lymphocytic infiltration of the thyroid gland, gradual destruction of the organ and production of thyroid specific auto antibodies (antithyroid peroxidase and antithyroglobulin antibodies). There are evidences that cast doubt on the pathogenetic role of these antibodies in thyroid autoimmunity. It is very likely that cellular destruction is mediated by other cellular mechanisms, such as auto reactive T-lymphocytes, natural killer and cytokines. However, other studies performed in animal models have led to the conclusion that organ specific autoimmune thyroiditis should be regarded as a polygenic disease with a penetrance that is strongly influenced by environmental factors. According to our recent results, patients affected by autoimmune thyroiditis exhibited a decreased percentage of NK and CD25 + bearing cells significantly in comparison to normal controls. Altogether these data indicated that in the patients with autoimmune thyroid disease a certain degree of peripheral immune deficiency was present.
Keywords: autoimmune thyroiditis, natural killers, immune deficiency
Current Pharmaceutical Design
Title: Modifications of the Immune Responsiveness in Patients with Autoimmune Thyroiditis: Evidence for a Systemic Immune Alteration
Volume: 9 Issue: 24
Author(s): A. Ciampolillo, E. Guastamacchia, L. Amati, T. Magrone, I. Munno, E. Jirillo, V. Triggiani, R. Fallacara and E. Tafaro
Affiliation:
Keywords: autoimmune thyroiditis, natural killers, immune deficiency
Abstract: Hashimotos thyroiditis, the most common form of autoimmune thyroid disease, is characterised by lymphocytic infiltration of the thyroid gland, gradual destruction of the organ and production of thyroid specific auto antibodies (antithyroid peroxidase and antithyroglobulin antibodies). There are evidences that cast doubt on the pathogenetic role of these antibodies in thyroid autoimmunity. It is very likely that cellular destruction is mediated by other cellular mechanisms, such as auto reactive T-lymphocytes, natural killer and cytokines. However, other studies performed in animal models have led to the conclusion that organ specific autoimmune thyroiditis should be regarded as a polygenic disease with a penetrance that is strongly influenced by environmental factors. According to our recent results, patients affected by autoimmune thyroiditis exhibited a decreased percentage of NK and CD25 + bearing cells significantly in comparison to normal controls. Altogether these data indicated that in the patients with autoimmune thyroid disease a certain degree of peripheral immune deficiency was present.
Export Options
About this article
Cite this article as:
Ciampolillo A., Guastamacchia E., Amati L., Magrone T., Munno I., Jirillo E., Triggiani V., Fallacara R. and Tafaro E., Modifications of the Immune Responsiveness in Patients with Autoimmune Thyroiditis: Evidence for a Systemic Immune Alteration, Current Pharmaceutical Design 2003; 9 (24) . https://dx.doi.org/10.2174/1381612033454270
DOI https://dx.doi.org/10.2174/1381612033454270 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hormonal Therapy for Prostate Cancer: Toward Further Unraveling of Androgen Receptor Function
Anti-Cancer Agents in Medicinal Chemistry Opioid Analgesics Adverse Effects: The Other Side of the Coin
Current Pharmaceutical Design Brain-Skin Connection: Stress, Inflammation and Skin Aging
Inflammation & Allergy - Drug Targets (Discontinued) Editorial (Thematic Issue: Advances in the Diagnosis and Treatment of Polycystic Ovarian Syndrome)
Current Pharmaceutical Design III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment
Current Pharmaceutical Design Telomerase Therapeutics for Degenerative Diseases
Current Molecular Medicine Biochemical Markers of Autoimmune Diseases of the Nervous System
Current Pharmaceutical Design Matrix Metalloproteinases as Drug Targets in Preeclampsia
Current Drug Targets Prostate Cancer: Biology, Incidence, Detection Methods, Treatment Methods, and Vaccines
Current Topics in Medicinal Chemistry Potential Therapeutic Targets for Steroid-Resistant Asthma
Current Drug Targets Diabetes Mellitus Type 2 and Functional Foods of Plant Origin
Recent Patents on Biotechnology The Zinc Metallopeptidase Family: New Faces, New Functions
Protein & Peptide Letters Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism
Current Genomics Use of Metallomics in Environmental Pollution Assessment Using Mice Mus musculus/Mus spretus as Bioindicators
Current Analytical Chemistry Estrogen Receptor Polymorphisms: Significance to Human Physiology, Disease and Therapy
Recent Patents on DNA & Gene Sequences AMPK as a Potential Anticancer Target - Friend or Foe?
Current Pharmaceutical Design Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Current Pharmaceutical Design Histone Modifications as Molecular Targets in Nasopharyngeal Cancer
Current Medicinal Chemistry Neuropeptide - Adipose Tissue Communication and Intestinal Pathophysiology
Current Pharmaceutical Design Predictive Diagnostic Pathology in the Target Therapy Era in Breast Cancer
Current Drug Targets